News archive for The Department of Biomedicine

This phase IB/II trial is designed to investigate the safety and survival benefits for patients with recurrent glioblastoma with unmethylated MGMT promoter treated with Bortezomib and Temozolomide in a specific schedule.

Visual processing in the retina

In an article published in Aftenposten Viten, researcher Marte Innselset Flydal describes how she is planning to develop medicine for children suffering from the rare disease phenylketonuria.

Researcher's Grand Prix-cadidate Illimar Hugo Rekand is working to keep us healthy. He is investigating new opportunities for making new medicines in a world where antibiotic resistance is an increasing challenge.

Welcome to a 2-days workshop 17.-18. Oct. with the Andor Academy team and Bitplane (Imaris) representatives.

The post-synaptic protein Arc has been termed a master regulator of memory. In line with its homology to certain viral proteins, it has also been shown recently to form virus-like capsids. We have elucidated for the first time the 3D structure of full-length monomeric Arc.

Thanks to funding from the Faculty of Medicine MIC recently got a new confocal in house. It was installed before summer and is ready to use.

Injection of a genetically modified polio virus into the brain can give brain cancer patients several years more than normal treatment.